UBS’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

UBS’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$37.3M	Buy	704,638 +155,918	+28%	+$7.93M	0.03%	627
2014 Q2	$28.5M	Buy	548,720 +24,552	+5%	+$1.18M	0.02%	698
2014 Q1	$24.5M	Buy	524,168 +384,788	+276%	+$18.2M	0.02%	692
2013 Q4	$6.13M	Sell	139,380 -70,946	-34%	-$2.95M	0.01%	1679
2013 Q3	$8.09M	Sell	210,326 -5,052	-2%	-$191K	0.01%	1288
2013 Q2	$7.59M	Buy	+215,378	New	+$7.27M	0.01%	1255

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS's XPH Position: Q3 2014 in Review

UBS increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 28% in Q3 2014, buying an estimated $7.93M and bringing the position to 704,638 shares worth $37.3M. The position accounts for 0.03% of the portfolio, ranked #627.

UBS first reported a position in XPH in Q2 2013 and has held it in 6 quarters since. 74 funds tracked by Wall St. Rank hold XPH as of Q3 2014.

UBS held 704,638 shares of State Street SPDR S&P Pharmaceuticals ETF worth $37.3M as of Q3 2014.
UBS bought 155,918 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2014, an estimated $7.93M.
State Street SPDR S&P Pharmaceuticals ETF made up 0.03% of UBS's portfolio in Q3 2014, its #627 holding.
UBS first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 6 quarters since.
74 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.